Mark Poritz
Chief Tech/Sci/R&D Officer bij CO-DIAGNOSTICS, INC.
Profiel
Mark Poritz is currently the Chief Scientific Officer at Co-Diagnostics, Inc. He was previously the Chief Scientific Officer at Idaho Molecular, Inc. He holds a doctorate degree from the University of California and an undergraduate degree from Harvard College.
Actieve functies van Mark Poritz
Bedrijven | Functie | Begin |
---|---|---|
CO-DIAGNOSTICS, INC. | Chief Tech/Sci/R&D Officer | 01-11-2022 |
Eerdere bekende functies van Mark Poritz
Bedrijven | Functie | Einde |
---|---|---|
Idaho Molecular, Inc.
Idaho Molecular, Inc. BiotechnologyHealth Technology Part of Co-Diagnostics, Inc., Idaho Molecular, Inc. is a biotechnology company that develops molecular diagnostics test devices. The private company is based in South Salt Lake, UT. The CEO of the company is Kirk M. Ririe. Idaho Molecular was acquired by Co-Diagnostics, Inc. on December 31, 2021. | Chief Tech/Sci/R&D Officer | - |
Opleiding van Mark Poritz
University of California | Doctorate Degree |
Harvard College | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
CO-DIAGNOSTICS, INC. | Health Technology |
Bedrijven in privébezit | 1 |
---|---|
Idaho Molecular, Inc.
Idaho Molecular, Inc. BiotechnologyHealth Technology Part of Co-Diagnostics, Inc., Idaho Molecular, Inc. is a biotechnology company that develops molecular diagnostics test devices. The private company is based in South Salt Lake, UT. The CEO of the company is Kirk M. Ririe. Idaho Molecular was acquired by Co-Diagnostics, Inc. on December 31, 2021. | Health Technology |